Lilly Asia Ventures I Overview
Lilly Asia Ventures I General Information
Description
Lilly Asia Ventures I is a venture capital fund managed by Lilly Asia Ventures. The fund is located in Hong Kong, Hong Kong and invests in China. The fund targets investments in the pharmaceutical, biotechnology, life science and oncology sectors. The fund prefers minority stake. The fund investment amount ranges from USD 5 million to USD 15 million.
Contact Information
Fund Manager's Location
- Room 606, St. George's Building
- 2 Ice House Street
- Hong Kong
- Hong Kong
Lilly Asia Ventures I Investments (12)
Lilly Asia Ventures I has made a total of 12 investments. Its most recent deal was a Structure Therapeutics for . The deal was made on 01-Aug-2022.
withCompany Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Structure Therapeutics | 01-Aug-2022 | Drug Discovery | Clinical Trials - Phase 1 | |||
Betta Pharmaceuticals | 07-Nov-2016 | Pharmaceuticals | Profitable | |||
3Sbio | 30-May-2013 | Pharmaceuticals | Profitable | |||
Innovent Biologics | 16-Nov-2012 | Pharmaceuticals | Startup | |||
Novast | 12-Jun-2012 | Pharmaceuticals | Generating Revenue | |||
BrightGene Bio-Medical Technology Company | 20-Mar-2011 | Biotechnology | Generating Revenue | |||
CITIC Pharmaceuticals | 01-Mar-2010 | Medical Supplies | Generating Revenue | |||
Betta Pharmaceuticals | 01-Jan-2010 | Pharmaceuticals | Generating Revenue | |||
Novast | 03-Jul-2009 | Later Stage VC (Series C) | Pharmaceuticals | Generating Revenue | ||
Chipscreen | 01-Jan-2009 | Later Stage VC (Series B) | Drug Discovery | Generating Revenue |
Lilly Asia Ventures I Investment Strategy
Lilly Asia Ventures I Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Lilly Asia Ventures I Benchmark (28)
Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
---|---|---|---|---|---|
Ojes Venture Partners Fund | |||||
VenturEast Tenet Fund II | |||||
Footprint Ventures | |||||
Dynamic India Fund VII | |||||
Lilly Asia Ventures I | |||||
China Seed Ventures | 31-Dec-2013 | ||||
IDG Ventures Korea Fund | |||||
DT Ventures China Fund II | 31-Dec-2021 | ||||
FinTech GIMV Fund | |||||
China Environment Fund III | 31-Mar-2024 |
Lilly Asia Ventures I FAQs
-
What is Lilly Asia Ventures I?
Lilly Asia Ventures I is a venture capital fund managed by Lilly Asia Ventures.
-
Who manages Lilly Asia Ventures I?
Lilly Asia Ventures I is managed by Lilly Asia Ventures.
-
Where is Lilly Asia Ventures I domiciled?
Lilly Asia Ventures I is domiciled in Cayman Islands and China.
-
What is Lilly Asia Ventures I's size?
Lilly Asia Ventures I has a size of
. -
What type of fund is Lilly Asia Ventures I?
The fund type of Lilly Asia Ventures I is Venture.
-
What is the status of Lilly Asia Ventures I?
Lilly Asia Ventures I is closed.
-
What has Lilly Asia Ventures I invested in?
Lilly Asia Ventures I has made numerous investments in companies like Structure Therapeutics, Betta Pharmaceuticals, and 3Sbio within the Drug Discovery and Pharmaceuticals industries.
-
What has Lilly Asia Ventures I invested in recently?
Lilly Asia Ventures I's latest investment was on 01-Aug-2022 in Structure Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »